Compare Stocks

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNO United States Brent Oil Fund	$32.68 +1.0%	$31.31	$24.02 ▼ $33.91	$132.35M	0.2	595,584 shs	400,178 shs
MBX Microbix Biosystems	C$0.34 -2.9%	C$0.38	C$0.23 ▼ C$0.47	C$45.74M	0.28	69,960 shs	2,500 shs
SBTX Silverback Therapeutics	$8.09 -2.1%	$8.80	$2.80 ▼ $8.97	$291.71M	0.6	337,931 shs	534,599 shs

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNO United States Brent Oil Fund	-0.22%	+0.62%	+2.41%	+10.29%	+19.81%
MBX Microbix Biosystems	0.00%	-4.29%	-10.67%	-14.10%	-9.46%
SBTX Silverback Therapeutics	+0.61%	-8.83%	-9.53%	+29.47%	+26.49%

Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNO United States Brent Oil Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNO United States Brent Oil Fund	0.00	N/A	N/A	N/A
MBX Microbix Biosystems	3.00	Buy	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNO United States Brent Oil Fund	N/A	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	C$22.42M	2.04	C$0.08 per share	4.13	C$0.20 per share	1.68
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	$7.41 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNO United States Brent Oil Fund	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	C$3.72M	C$0.03	11.17	∞	N/A	16.57%	14.66%	1.87%	5/9/2024 (Estimated)
SBTX Silverback Therapeutics	-$89.48M	-$2.42	N/A	∞	N/A	N/A	-29.62%	-28.20%	N/A

Latest SBTX, BNO, MBX, and IXI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/14/2024	Q1 2024	MBX Microbix Biosystems	N/A	C$0.02	+C$0.02	C$0.02	C$8.10 million	C$8.41 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNO United States Brent Oil Fund	N/A	N/A	N/A	N/A	N/A
MBX Microbix Biosystems	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNO United States Brent Oil Fund	N/A	N/A	N/A
MBX Microbix Biosystems	24.53	8.53	5.57
SBTX Silverback Therapeutics	N/A	67.87	67.87

Ownership

Institutional Ownership

Company	Institutional Ownership
BNO United States Brent Oil Fund	N/A
MBX Microbix Biosystems	0.42%
SBTX Silverback Therapeutics	74.89%

Insider Ownership

Company	Insider Ownership
BNO United States Brent Oil Fund	N/A
MBX Microbix Biosystems	14.07%
SBTX Silverback Therapeutics	34.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BNO United States Brent Oil Fund	N/A	4.05 million	N/A	Not Optionable
MBX Microbix Biosystems	N/A	136.55 million	N/A	Not Optionable
SBTX Silverback Therapeutics	83	36.06 million	23.65 million	Not Optionable

SBTX, BNO, MBX, and IXI Headlines

Source	Headline
	Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2.8% americanbankingnews.com - April 25 at 1:48 AM
	Silverback Therapeutics (NASDAQ:SBTX) Trading Down 2% marketbeat.com - April 3 at 2:15 AM
	ARS Pharmaceuticals Inc (SPRY) uk.investing.com - May 11 at 1:32 PM
	Wild Isles wwf.org.uk - March 12 at 9:31 AM
	A look back at RNA Therapeutics – day one pharmaphorum.com - February 24 at 12:35 AM
	SPRY ARS Pharmaceuticals, Inc. seekingalpha.com - January 24 at 8:04 PM
	ARS Pharma CEO Richard Lowenthal Holds 8% Silverback Stake After Merger 247wallst.com - November 22 at 6:29 AM
	Dr. Sarina Tanimoto Discloses Position in SBTX / Silverback Therapeutics nasdaq.com - November 18 at 8:19 PM
	ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis finance.yahoo.com - November 10 at 6:41 PM
	ARS Pharmaceuticals Closes Merger with Silverback Therapeutics finance.yahoo.com - November 8 at 5:59 PM
	Silverback : FDA Accepts ARS Pharm's NDA For Neffy For Treatment Of Allergic Reactions markets.businessinsider.com - October 28 at 8:15 AM
	FDA accepts ARS Pharma’s NDA for Neffy thepharmaletter.com - October 24 at 10:29 AM
	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HIL, SBTX, COWN, AERI kentuckytoday.com - October 23 at 7:22 PM
	Silverback Therapeutics, Inc. announces the FDA’s acceptance of ARS Pharmaceuticals’ NDA for neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (type I) including Anaphylaxis finance.yahoo.com - October 21 at 7:59 AM
	Is Silverback Therapeutics Inc (SBTX) Stock a Good Investment? aaii.com - October 19 at 11:52 AM
	SHAREHOLDER ALERT: The M&A Class Action Firm is Investigating the Merger – RFP, SBTX, AAWW, COWN bakersfield.com - October 12 at 11:07 PM
	INVESTIGATION ALERT: Halper Sadeh LLC Investigates CVET, SBTX, IRBT markets.businessinsider.com - September 17 at 5:10 AM
	SBTX Silverback Therapeutics, Inc. seekingalpha.com - September 15 at 10:58 PM
	SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT markets.businessinsider.com - September 6 at 11:53 AM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY markets.businessinsider.com - August 23 at 6:32 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, HNGR, SBTX apnews.com - August 17 at 12:02 PM
	SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates IEA, BBQ, SBTX apnews.com - August 11 at 1:33 AM
	SHAREHOLDER ALERT: Weiss Law Reminds SBTX, LJPC, CNVY, and DRE Shareholders About Its Ongoing Investigations morningstar.com - July 30 at 7:00 AM
	INVESTIGATION ALERT: Halper Sadeh LLP Investigates HNGR, SBTX, IEA, ZY apnews.com - July 28 at 2:21 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

United States Brent Oil Fund

NYSEARCA:BNO

The United States Brent Oil Fund, LP (BNO) is an exchange-traded fund that is based on the Front Month Brent Crude Oil index. The fund tracks the Brent oil spot price using near-month ICE futures contracts. BNO was launched on Jun 2, 2010 and is managed by US Commodity Funds.

Microbix Biosystems

TSE:MBX

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Silverback Therapeutics

NASDAQ:SBTX

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial